Replication and single-cycle delivery of SARS-CoV-2 replicons
Molecular virology tools are critical for basic studies of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and for developing new therapeutics. Experimental …
syndrome coronavirus 2 (SARS-CoV-2) and for developing new therapeutics. Experimental …
Sensitive lateral flow immunoassay based on specific peptide and superior oxidase mimics with a universal dual-mode significant signal amplification
T Dong, X Zhang, J Yuan, Z Lin, P Yin, H Yu… - Analytical …, 2023 - ACS Publications
Rapid and sensitive antigen detection using a lateral flow immunoassay (LFIA) is crucial for
diagnosing infectious diseases due to its simplicity, speed, and user-friendly features …
diagnosing infectious diseases due to its simplicity, speed, and user-friendly features …
Recent Progress in Phage‐Based Nanoplatforms for Tumor Therapy
XT Li, SY Peng, SM Feng, TY Bao, SZ Li, SY Li - Small, 2024 - Wiley Online Library
Nanodrug delivery systems have demonstrated a great potential for tumor therapy with the
development of nanotechnology. Nonetheless, traditional drug delivery systems are faced …
development of nanotechnology. Nonetheless, traditional drug delivery systems are faced …
Pseudoviruses, a safer toolbox for vaccine development against enveloped viruses
Introduction Pseudoviruses are recombinant, replication-incompetent, viral particles
designed to mimic the surface characteristics of native enveloped viruses. They are a safer …
designed to mimic the surface characteristics of native enveloped viruses. They are a safer …
Borneol ester derivatives as entry inhibitors of a wide spectrum of SARS-CoV-2 viruses
OI Yarovaya, DN Shcherbakov, SS Borisevich… - Viruses, 2022 - mdpi.com
In the present work we studied the antiviral activity of the home library of monoterpenoid
derivatives using the pseudoviral systems of our development, which have glycoproteins of …
derivatives using the pseudoviral systems of our development, which have glycoproteins of …
Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer's …
J Chen, J Chen, Z Lei, F Zhang, LH Zeng, X Wu… - Translational …, 2023 - nature.com
Although there are indications of a trend towards less severe acute respiratory symptoms
and a decline in overall lethality from the novel Coronavirus Disease 2019 (COVID-19) …
and a decline in overall lethality from the novel Coronavirus Disease 2019 (COVID-19) …
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) binding to angiotensin‐converting enzyme 2
J Zhu, H Yan, M Shi, M Zhang, J Lu… - Phytotherapy …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) causes coronavirus
disease 2019 (COVID‐19), a respiratory illness that poses a serious threat to global public …
disease 2019 (COVID‐19), a respiratory illness that poses a serious threat to global public …
A pseudovirus-based platform to measure neutralizing antibodies in Mexico using SARS-CoV-2 as proof-of-concept
JA Cruz-Cardenas, M Gutierrez, A López-Arredondo… - Scientific Reports, 2022 - nature.com
The gold-standard method to evaluate a functional antiviral immune response is to titer
neutralizing antibodies (NAbs) against a viral pathogen. This is historically performed using …
neutralizing antibodies (NAbs) against a viral pathogen. This is historically performed using …
Characterization and discrimination of spike protein in SARS‐CoV‐2 virus‐like particles via surface‐enhanced Raman spectroscopy
Non‐infectious virus‐like particles (VLPs) are excellent structures for development of many
biomedical applications such as drug delivery systems, vaccine production platforms, and …
biomedical applications such as drug delivery systems, vaccine production platforms, and …
Development of a cell-based SARS-CoV-2 pseudovirus neutralization assay using imaging and flow cytometry analysis
JR Izac, EJ Kwee, L Tian, E Elsheikh… - International Journal of …, 2023 - mdpi.com
COVID-19 is an ongoing, global pandemic caused by the novel, highly infectious SARS-CoV-
2 virus. Efforts to mitigate the effects of SARS-CoV-2, such as mass vaccination and …
2 virus. Efforts to mitigate the effects of SARS-CoV-2, such as mass vaccination and …